Atom Investors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,119
Closed -$396K 767
2025
Q4
$396K Buy
4,119
+1,774
+76% +$172K 0.03% 409
2025
Q3
$223K Buy
2,345
+7
+0.3% +$643 0.02% 494
2025
Q2
$204K Sell
2,338
-5,073
-68% -$430K 0.02% 512
2025
Q1
$666K Sell
7,411
-27,951
-79% -$2.5M 0.08% 266
2024
Q4
$2.82M Buy
+35,362
New +$3.06M 0.35% 94
2024
Q3
Sell
-29,495
Closed -$2.32M 548
2024
Q2
$2.32M Sell
29,495
-39,268
-57% -$3.22M 0.23% 140
2024
Q1
$5.99M Buy
68,763
+38,237
+125% +$3.26M 0.75% 17
2023
Q4
$2.51M Buy
+30,526
New +$2.33M 0.44% 65

Other funds holding MDT

Atom Investors's MDT Position: Q1 2026 in Review

Atom Investors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 4,119 shares — an estimated $396K sold.

Atom Investors first reported a position in MDT in Q4 2023 and held it in 8 quarters. The position peaked at $5.99M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Atom Investors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 4,119 Medtronic shares in Q1 2026, an estimated $396K.
  • Atom Investors first reported a position in Medtronic in Q4 2023 and held it in 8 quarters.
  • Atom Investors's Medtronic position peaked at $5.99M in Q1 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.